| Year |
Citation |
Score |
| 2020 |
Gallyas F, Sumegi B. Mitochondrial Protection by PARP Inhibition. International Journal of Molecular Sciences. 21. PMID 32316192 DOI: 10.3390/Ijms21082767 |
0.33 |
|
| 2020 |
Gallyas F, Sumegi B, Szabo C. Role of Akt Activation in PARP Inhibitor Resistance in Cancer. Cancers. 12. PMID 32106627 DOI: 10.3390/Cancers12030532 |
0.323 |
|
| 2019 |
Svab G, Doczi J, Gerencser AA, Ambrus A, Gallyas F, Sümegi B, Tretter L. The Mitochondrial Targets of Neuroprotective Drug Vinpocetine on Primary Neuron Cultures, Brain Capillary Endothelial Cells, Synaptosomes, and Brain Mitochondria. Neurochemical Research. PMID 31535355 DOI: 10.1007/S11064-019-02871-9 |
0.34 |
|
| 2019 |
Cseh AM, Fabian Z, Quintana-Cabrera R, Szabo A, Eros K, Soriano ME, Gallyas F, Scorrano L, Sumegi B. PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells. Frontiers in Physiology. 10: 538. PMID 31133874 DOI: 10.3389/Fphys.2019.00538 |
0.339 |
|
| 2019 |
Kovacs K, Vaczy A, Fekete K, Kovari P, Atlasz T, Reglodi D, Gabriel R, Gallyas F, Sumegi B. PARP Inhibitor Protects Against Chronic Hypoxia/Reoxygenation-Induced Retinal Injury by Regulation of MAPKs, HIF1α, Nrf2, and NFκB. Investigative Ophthalmology & Visual Science. 60: 1478-1490. PMID 30973576 DOI: 10.1167/Iovs.18-25936 |
0.307 |
|
| 2018 |
Tapodi A, Bognár Z, Szabo C, Gallyas F, Sümegi B, Hocsák E. PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome. Biochemical Pharmacology. PMID 30296409 DOI: 10.1016/J.Bcp.2018.10.005 |
0.368 |
|
| 2018 |
Szabo A, Sumegi K, Fekete K, Hocsak E, Debreceni B, Setalo G, Kovacs K, Deres L, Kengyel A, Kovacs D, Mandl J, Nyitrai M, Febbraio MA, Gallyas F, Sumegi B. Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases. Biochemical Pharmacology. PMID 29378182 DOI: 10.1016/J.Bcp.2018.01.038 |
0.326 |
|
| 2017 |
Bognar Z, Fekete K, Antus C, Hocsak E, Bognar R, Tapodi A, Boronkai A, Farkas N, Gallyas F, Sumegi B, Szanto A. Desethylamiodarone-A metabolite of amiodarone-Induces apoptosis on T24 human bladder cancer cells via multiple pathways. Plos One. 12: e0189470. PMID 29220397 DOI: 10.1371/Journal.Pone.0189470 |
0.349 |
|
| 2017 |
Hocsak E, Szabo V, Kalman N, Antus C, Cseh A, Sumegi K, Eros K, Hegedus Z, Gallyas F, Sumegi B, Racz B. PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway. Free Radical Biology & Medicine. PMID 28457938 DOI: 10.1016/J.Freeradbiomed.2017.04.018 |
0.384 |
|
| 2017 |
Eros K, Magyar K, Deres L, Skazel A, Riba A, Vamos Z, Kalai T, Gallyas F, Sumegi B, Toth K, Halmosi R. Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats. Plos One. 12: e0174401. PMID 28339485 DOI: 10.1371/Journal.Pone.0174401 |
0.337 |
|
| 2017 |
Sumegi K, Fekete K, Antus C, Debreceni B, Hocsak E, Gallyas F, Sumegi B, Szabo A. BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species. Plos One. 12: e0169372. PMID 28046125 DOI: 10.1371/Journal.Pone.0169372 |
0.339 |
|
| 2015 |
Solti I, Kvell K, Talaber G, Veto S, Acs P, Gallyas F, Illes Z, Fekete K, Zalan P, Szanto A, Bognar Z. Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis. Plos One. 10: e0129217. PMID 26053248 DOI: 10.1371/Journal.Pone.0129217 |
0.31 |
|
| 2015 |
Turi Z, Hocsak E, Racz B, Szabo A, Balogh A, Sumegi B, Gallyas F. Role of mitochondrial network stabilisation by a human small heat shock protein in tumour malignancy. Journal of Cancer. 6: 470-6. PMID 25874011 DOI: 10.7150/Jca.11494 |
0.383 |
|
| 2015 |
Priber J, Fonai F, Jakus PB, Racz B, Chinopoulos C, Tretter L, Gallyas F, Sumegi B, Veres B. Cyclophilin D disruption attenuates lipopolysaccharide-induced inflammatory response in primary mouse macrophages. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 93: 241-50. PMID 25728038 DOI: 10.1139/Bcb-2014-0120 |
0.32 |
|
| 2014 |
Kiss T, Kovacs K, Komocsi A, Tornyos A, Zalan P, Sumegi B, Gallyas F, Kovacs K. Novel mechanisms of sildenafil in pulmonary hypertension involving cytokines/chemokines, MAP kinases and Akt. Plos One. 9: e104890. PMID 25133539 DOI: 10.1371/Journal.Pone.0104890 |
0.312 |
|
| 2014 |
Deres L, Bartha E, Palfi A, Eros K, Riba A, Lantos J, Kalai T, Hideg K, Sumegi B, Gallyas F, Toth K, Halmosi R. PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms. Plos One. 9: e102148. PMID 25014216 DOI: 10.1371/Journal.Pone.0102148 |
0.309 |
|
| 2014 |
Magyar K, Deres L, Eros K, Bruszt K, Seress L, Hamar J, Hideg K, Balogh A, Gallyas F, Sumegi B, Toth K, Halmosi R. A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats. Biochimica Et Biophysica Acta. 1842: 935-44. PMID 24657811 DOI: 10.1016/J.Bbadis.2014.03.008 |
0.302 |
|
| 2013 |
Kalmar-Nagy K, Degrell P, Szabo A, Sumegi K, Wittmann I, Gallyas F, Sumegi B. PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade. Plos One. 8: e81928. PMID 24312605 DOI: 10.1371/Journal.Pone.0081928 |
0.344 |
|
| 2013 |
Bognar E, Sarszegi Z, Szabo A, Debreceni B, Kalman N, Tucsek Z, Sumegi B, Gallyas F. Antioxidant and anti-inflammatory effects in RAW264.7 macrophages of malvidin, a major red wine polyphenol. Plos One. 8: e65355. PMID 23755222 DOI: 10.1371/Journal.Pone.0065355 |
0.34 |
|
| 2013 |
Jakus PB, Kalman N, Antus C, Radnai B, Tucsek Z, Gallyas F, Sumegi B, Veres B. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol. The Journal of Nutritional Biochemistry. 24: 819-23. PMID 22925919 DOI: 10.1016/J.Jnutbio.2012.04.017 |
0.316 |
|
| 2012 |
Radnai B, Antus C, Racz B, Engelmann P, Priber JK, Tucsek Z, Veres B, Turi Z, Lorand T, Sumegi B, Gallyas F. Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation. Molecular Cancer. 11: 34. PMID 22583868 DOI: 10.1186/1476-4598-11-34 |
0.357 |
|
| 2012 |
Sarszegi Z, Bognar E, Gaszner B, Kónyi A, Gallyas F, Sumegi B, Berente Z. BGP-15, a PARP-inhibitor, prevents imatinib-induced cardiotoxicity by activating Akt and suppressing JNK and p38 MAP kinases. Molecular and Cellular Biochemistry. 365: 129-37. PMID 22350755 DOI: 10.1007/S11010-012-1252-8 |
0.34 |
|
| 2011 |
Szabo A, Balog M, Mark L, Montsko G, Turi Z, Gallyas F, Sumegi B, Kalai T, Hideg K, Kovacs K. Induction of mitochondrial destabilization and necrotic cell death by apolar mitochondria-directed SOD mimetics. Mitochondrion. 11: 476-87. PMID 21292036 DOI: 10.1016/J.Mito.2011.01.006 |
0.36 |
|
| 2010 |
Racz B, Hanto K, Tapodi A, Solti I, Kalman N, Jakus P, Kovacs K, Debreceni B, Gallyas F, Sumegi B. Regulation of MKP-1 expression and MAPK activation by PARP-1 in oxidative stress: a new mechanism for the cytoplasmic effect of PARP-1 activation. Free Radical Biology & Medicine. 49: 1978-88. PMID 20920579 DOI: 10.1016/J.Freeradbiomed.2010.09.026 |
0.355 |
|
| 2010 |
Hocsak E, Racz B, Szabo A, Pozsgai E, Szigeti A, Szigeti E, Gallyas F, Sumegi B, Javor S, Bellyei S. TIP47 confers resistance to taxol-induced cell death by preventing the nuclear translocation of AIF and Endonuclease G. European Journal of Cell Biology. 89: 853-61. PMID 20708296 DOI: 10.1016/J.Ejcb.2010.06.010 |
0.359 |
|
| 2010 |
Atlasz T, Szabadfi K, Kiss P, Racz B, Gallyas F, Tamas A, Gaal V, Marton Z, Gabriel R, Reglodi D. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects. Annals of the New York Academy of Sciences. 1200: 128-39. PMID 20633141 DOI: 10.1111/J.1749-6632.2010.05512.X |
0.32 |
|
| 2010 |
Hocsak E, Racz B, Szabo A, Mester L, Rapolti E, Pozsgai E, Javor S, Bellyei S, Gallyas F, Sumegi B, Szigeti A. TIP47 protects mitochondrial membrane integrity and inhibits oxidative-stress-induced cell death. Febs Letters. 584: 2953-60. PMID 20556887 DOI: 10.1016/J.Febslet.2010.05.027 |
0.351 |
|
| 2010 |
Horvath G, Racz B, Reglodi D, Kovacs K, Kiss P, Gallyas F, Bognar Z, Szabo A, Magyarlaki T, Laszlo E, Lubics A, Tamas A, Toth G, Szakaly P. Effects of PACAP on mitochondrial apoptotic pathways and cytokine expression in rats subjected to renal ischemia/reperfusion. Journal of Molecular Neuroscience : Mn. 42: 411-8. PMID 20229361 DOI: 10.1007/S12031-010-9342-0 |
0.346 |
|
| 2010 |
Veto S, Acs P, Bauer J, Lassmann H, Berente Z, Setalo G, Borgulya G, Sumegi B, Komoly S, Gallyas F, Illes Z. Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death. Brain : a Journal of Neurology. 133: 822-34. PMID 20157013 DOI: 10.1093/Brain/Awp337 |
0.363 |
|
| 2010 |
Racz B, Horvath G, Reglodi D, Gasz B, Kiss P, Gallyas F, Sumegi B, Toth G, Nemeth A, Lubics A, Tamas A. PACAP ameliorates oxidative stress in the chicken inner ear: an in vitro study. Regulatory Peptides. 160: 91-8. PMID 19969027 DOI: 10.1016/J.Regpep.2009.12.003 |
0.362 |
|
| 2010 |
Szigeti A, Hocsak E, Rapolti E, Racz B, Boronkai A, Pozsgai E, Debreceni B, Bognar Z, Bellyei S, Sumegi B, Gallyas F. Facilitation of mitochondrial outer and inner membrane permeabilization and cell death in oxidative stress by a novel Bcl-2 homology 3 domain protein. The Journal of Biological Chemistry. 285: 2140-51. PMID 19901022 DOI: 10.1074/Jbc.M109.015222 |
0.354 |
|
| 2009 |
Boronkai A, Bellyei S, Szigeti A, Pozsgai E, Bognar Z, Sumegi B, Gallyas F. Potentiation of paclitaxel-induced apoptosis by galectin-13 overexpression via activation of Ask-1-p38-MAP kinase and JNK/SAPK pathways and suppression of Akt and ERK1/2 activation in U-937 human macrophage cells. European Journal of Cell Biology. 88: 753-63. PMID 19717209 DOI: 10.1016/J.Ejcb.2009.07.005 |
0.364 |
|
| 2009 |
Mester L, Szabo A, Atlasz T, Szabadfi K, Reglodi D, Kiss P, Racz B, Tamas A, Gallyas F, Sumegi B, Hocsak E, Gabriel R, Kovacs K. Protection against chronic hypoperfusion-induced retinal neurodegeneration by PARP inhibition via activation of PI-3-kinase Akt pathway and suppression of JNK and p38 MAP kinases. Neurotoxicity Research. 16: 68-76. PMID 19526300 DOI: 10.1007/S12640-009-9049-6 |
0.382 |
|
| 2009 |
Szanto A, Hellebrand EE, Bognar Z, Tucsek Z, Szabo A, Gallyas F, Sumegi B, Varbiro G. PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol. Biochemical Pharmacology. 77: 1348-57. PMID 19426673 DOI: 10.1016/J.Bcp.2009.01.008 |
0.352 |
|
| 2009 |
Gallyas F, Pál J, Bukovics P. Supravital microwave experiments support that the formation of "dark" neurons is propelled by phase transition in an intracellular gel system. Brain Research. 1270: 152-6. PMID 19324025 DOI: 10.1016/J.Brainres.2009.03.020 |
0.35 |
|
| 2009 |
Kovacs K, Hanto K, Bognar Z, Tapodi A, Bognar E, Kiss GN, Szabo A, Rappai G, Kiss T, Sumegi B, Gallyas F. Prevalent role of Akt and ERK activation in cardioprotective effect of Ca(2+) channel- and beta-adrenergic receptor blockers. Molecular and Cellular Biochemistry. 321: 155-64. PMID 18975057 DOI: 10.1007/S11010-008-9929-8 |
0.323 |
|
| 2008 |
Gallyas F, Kiglics V, Baracskay P, Juhász G, Czurkó A. The mode of death of epilepsy-induced "dark" neurons is neither necrosis nor apoptosis: an electron-microscopic study. Brain Research. 1239: 207-15. PMID 18801347 DOI: 10.1016/J.Brainres.2008.08.069 |
0.393 |
|
| 2008 |
Bukovics P, Pál J, Gallyas F. Aldehyde fixation is not necessary for the formation of "dark" neurons. Acta Neuropathologica. 116: 463-4. PMID 18696090 DOI: 10.1007/S00401-008-0424-9 |
0.38 |
|
| 2008 |
Racz B, Horvath G, Faluhelyi N, Nagy AD, Tamas A, Kiss P, Gallyas F, Toth G, Gaszner B, Csernus V, Reglodi D. Effects of PACAP on the circadian changes of signaling pathways in chicken pinealocytes. Journal of Molecular Neuroscience : Mn. 36: 220-6. PMID 18592414 DOI: 10.1007/S12031-008-9112-4 |
0.305 |
|
| 2008 |
Rácz B, Gasz B, Gallyas F, Kiss P, Tamás A, Szántó Z, Lubics A, Lengvári I, Tóth G, Hegyi O, Roth E, Reglodi D. PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis. Regulatory Peptides. 145: 105-15. PMID 17981349 DOI: 10.1016/j.regpep.2007.09.015 |
0.301 |
|
| 2007 |
Rácz B, Gallyas F, Kiss P, Tamás A, Lubics A, Lengvári I, Röth E, Tóth G, Hegyi O, Verzál Z, Fabricsek C, Reglódi D. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats. Neurotoxicity Research. 12: 95-104. PMID 17967733 DOI: 10.1007/Bf03033918 |
0.38 |
|
| 2007 |
Racz B, Reglodi D, Fodor B, Gasz B, Lubics A, Gallyas F, Roth E, Borsiczky B. Hyperosmotic stress-induced apoptotic signaling pathways in chondrocytes. Bone. 40: 1536-43. PMID 17392049 DOI: 10.1016/J.Bone.2007.02.011 |
0.351 |
|
| 2007 |
Kovács B, Bukovics P, Gallyas F. Morphological effects of transcardially perfused SDS on the rat brain. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 99: 425-32. PMID 17371297 DOI: 10.1042/Bc20060128 |
0.383 |
|
| 2007 |
Kövesdi E, Pál J, Gallyas F. The fate of "dark" neurons produced by transient focal cerebral ischemia in a non-necrotic and non-excitotoxic environment: neurobiological aspects. Brain Research. 1147: 272-83. PMID 17349980 DOI: 10.1016/J.Brainres.2007.02.011 |
0.385 |
|
| 2007 |
Bellyei S, Szigeti A, Pozsgai E, Boronkai A, Gomori E, Hocsak E, Farkas R, Sumegi B, Gallyas F. Preventing apoptotic cell death by a novel small heat shock protein. European Journal of Cell Biology. 86: 161-71. PMID 17275951 DOI: 10.1016/J.Ejcb.2006.12.004 |
0.317 |
|
| 2007 |
Bellyei S, Szigeti A, Boronkai A, Pozsgai E, Gomori E, Melegh B, Janaky T, Bognar Z, Hocsak E, Sumegi B, Gallyas F. Inhibition of cell death by a novel 16.2 kD heat shock protein predominantly via Hsp90 mediated lipid rafts stabilization and Akt activation pathway. Apoptosis : An International Journal On Programmed Cell Death. 12: 97-112. PMID 17136496 DOI: 10.1007/S10495-006-0486-X |
0.338 |
|
| 2006 |
Szigeti A, Bellyei S, Gasz B, Boronkai A, Hocsak E, Minik O, Bognar Z, Varbiro G, Sumegi B, Gallyas F. Induction of necrotic cell death and mitochondrial permeabilization by heme binding protein 2/SOUL. Febs Letters. 580: 6447-54. PMID 17098234 DOI: 10.1016/J.Febslet.2006.10.067 |
0.342 |
|
| 2006 |
Rácz B, Gallyas F, Kiss P, Tóth G, Hegyi O, Gasz B, Borsiczky B, Ferencz A, Roth E, Tamás A, Lengvári I, Lubics A, Reglodi D. The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways. Regulatory Peptides. 137: 20-6. PMID 16945433 DOI: 10.1016/J.Regpep.2006.02.009 |
0.363 |
|
| 2006 |
Bognar Z, Kalai T, Palfi A, Hanto K, Bognar B, Mark L, Szabo Z, Tapodi A, Radnai B, Sarszegi Z, Szanto A, Gallyas F, Hideg K, Sumegi B, Varbiro G. A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death. Free Radical Biology & Medicine. 41: 835-48. PMID 16895804 DOI: 10.1016/J.Freeradbiomed.2006.06.004 |
0.378 |
|
| 2006 |
Rácz B, Tamás A, Kiss P, Tóth G, Gasz B, Borsiczky B, Ferencz A, Gallyas F, Roth E, Reglodi D. Involvement of ERK and CREB signaling pathways in the protective effect of PACAP in monosodium glutamate-induced retinal lesion. Annals of the New York Academy of Sciences. 1070: 507-11. PMID 16891269 DOI: 10.1196/Annals.1317.070 |
0.325 |
|
| 2006 |
Gasz B, Rácz B, Röth E, Borsiczky B, Tamás A, Boronkai A, Gallyas F, Tóth G, Reglodi D. PACAP inhibits oxidative stress-induced activation of MAP kinase-dependent apoptotic pathway in cultured cardiomyocytes. Annals of the New York Academy of Sciences. 1070: 293-7. PMID 16891268 DOI: 10.1196/Annals.1317.029 |
0.36 |
|
| 2006 |
Gallyas F, Gasz B, Szigeti A, Mázló M. Pathological circumstances impair the ability of "dark" neurons to undergo spontaneous recovery. Brain Research. 1110: 211-20. PMID 16872583 DOI: 10.1016/J.Brainres.2006.06.078 |
0.361 |
|
| 2006 |
Palfi A, Toth A, Hanto K, Deres P, Szabados E, Szereday Z, Kulcsar G, Kalai T, Hideg K, Gallyas F, Sumegi B, Toth K, Halmosi R. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway. Journal of Molecular and Cellular Cardiology. 41: 149-59. PMID 16716347 DOI: 10.1016/J.Yjmcc.2006.03.427 |
0.305 |
|
| 2006 |
Kellermayer R, Zsombok A, Auer T, Gallyas F. Electrically induced gel-to-gel phase-transition in neurons. Cell Biology International. 30: 175-82. PMID 16376580 DOI: 10.1016/J.Cellbi.2005.11.002 |
0.34 |
|
| 2006 |
Kovacs K, Toth A, Deres P, Kalai T, Hideg K, Gallyas F, Sumegi B. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion. Biochemical Pharmacology. 71: 441-52. PMID 16337154 DOI: 10.1016/J.Bcp.2005.05.036 |
0.334 |
|
| 2005 |
Tapodi A, Debreceni B, Hanto K, Bognar Z, Wittmann I, Gallyas F, Varbiro G, Sumegi B. Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress. The Journal of Biological Chemistry. 280: 35767-75. PMID 16115861 DOI: 10.1074/Jbc.M507075200 |
0.375 |
|
| 2005 |
Zsombok A, Tóth Z, Gallyas F. Basophilia, acidophilia and argyrophilia of "dark" (compacted) neurons during their formation, recovery or death in an otherwise undamaged environment. Journal of Neuroscience Methods. 142: 145-52. PMID 15652628 DOI: 10.1016/J.Jneumeth.2004.08.005 |
0.372 |
|
| 2005 |
Gallyas F, Csordás A, Schwarcz A, Mázló M. "Dark" (compacted) neurons may not die through the necrotic pathway. Experimental Brain Research. 160: 473-86. PMID 15480602 DOI: 10.1007/S00221-004-2037-4 |
0.386 |
|
| 2004 |
Mázló M, Gasz B, Szigeti A, Zsombok A, Gallyas F. Debris of "dark" (compacted) neurones are removed from an otherwise undamaged environment mainly by astrocytes via blood vessels. Journal of Neurocytology. 33: 557-67. PMID 15906162 DOI: 10.1007/S11068-004-0517-5 |
0.367 |
|
| 2004 |
Gallyas F, Farkas O, Mázló M. Gel-to-gel phase transition may occur in mammalian cells: Mechanism of formation of "dark" (compacted) neurons. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 96: 313-24. PMID 15145535 DOI: 10.1016/J.Biolcel.2004.01.009 |
0.372 |
|
| 2004 |
Veres B, Radnai B, Gallyas F, Varbiro G, Berente Z, Osz E, Sumegi B. Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. The Journal of Pharmacology and Experimental Therapeutics. 310: 247-55. PMID 14999056 DOI: 10.1124/Jpet.104.065151 |
0.323 |
|
| 2003 |
Varbiro G, Toth A, Tapodi A, Bognar Z, Veres B, Sumegi B, Gallyas F. Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition. The Journal of Pharmacology and Experimental Therapeutics. 307: 615-25. PMID 12970391 DOI: 10.1124/Jpet.103.053553 |
0.329 |
|
| 2003 |
Veres B, Gallyas F, Varbiro G, Berente Z, Osz E, Szekeres G, Szabo C, Sumegi B. Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochemical Pharmacology. 65: 1373-82. PMID 12694878 DOI: 10.1016/S0006-2952(03)00077-7 |
0.322 |
|
| 2003 |
Csordás A, Mázló M, Gallyas F. Recovery versus death of "dark" (compacted) neurons in non-impaired parenchymal environment: light and electron microscopic observations. Acta Neuropathologica. 106: 37-49. PMID 12665989 DOI: 10.1007/S00401-003-0694-1 |
0.388 |
|
| 2003 |
Varbiro G, Toth A, Tapodi A, Veres B, Sumegi B, Gallyas F. Concentration dependent mitochondrial effect of amiodarone. Biochemical Pharmacology. 65: 1115-28. PMID 12663047 DOI: 10.1016/S0006-2952(02)01660-X |
0.32 |
|
| 2002 |
Jagtap P, Soriano FG, Virág L, Liaudet L, Mabley J, Szabó E, Haskó G, Marton A, Lorigados CB, Gallyas F, Sümegi B, Hoyt DG, Baloglu E, VanDuzer J, Salzman AL, et al. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Critical Care Medicine. 30: 1071-82. PMID 12006805 DOI: 10.1097/00003246-200205000-00019 |
0.316 |
|
| 2002 |
Racz I, Tory K, Gallyas F, Berente Z, Osz E, Jaszlits L, Bernath S, Sumegi B, Rabloczky G, Literati-Nagy P. BGP-15 - a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin without compromising its antitumor activity. Biochemical Pharmacology. 63: 1099-111. PMID 11931842 DOI: 10.1016/S0006-2952(01)00935-2 |
0.334 |
|
| 2001 |
Varbiro G, Veres B, Gallyas F, Sumegi B. Direct effect of Taxol on free radical formation and mitochondrial permeability transition. Free Radical Biology & Medicine. 31: 548-58. PMID 11498288 DOI: 10.1016/S0891-5849(01)00616-5 |
0.339 |
|
| 2001 |
Seress L, Abrahám H, Paleszter M, Gallyas F. Granule cells are the main source of excitatory input to a subpopulation of GABAergic hippocampal neurons as revealed by electron microscopic double staining for zinc histochemistry and parvalbumin immunocytochemistry. Experimental Brain Research. 136: 456-62. PMID 11291726 DOI: 10.1007/S002210000601 |
0.322 |
|
| 2001 |
Seress L, Ábrahám H, Paleszter M, Gallyas F. Erratum: Granule cells are the main source of excitatory input to a subpopulation of GABAergic hippocampal neurons as revealed by electron microscopic double staining for zinc histochemistry and parvalbumin immunocytochemistry (Experimental Brain Research (2001) 136 (456-462)) Experimental Brain Research. 137. DOI: 10.1007/S002210100714 |
0.325 |
|
| 1999 |
Szabados E, Fischer GM, Gallyas F, Kispal G, Sumegi B. Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia-reperfusion in perfused rat heart. Free Radical Biology & Medicine. 27: 1103-13. PMID 10569643 DOI: 10.1016/S0891-5849(99)00151-3 |
0.325 |
|
| 1996 |
Horváth Z, Hsu M, Pierre E, Vadi D, Gallyas F, Buzsáki G. Structural impairment of hippocampal neurons following a single epileptic afterdischarge. Epilepsy Research. Supplement. 12: 325-34. PMID 9302532 |
0.559 |
|
| 1994 |
Hsu M, Sik A, Gallyas F, Horváth Z, Buzsáki G. Short-term and long-term changes in the postischemic hippocampus. Annals of the New York Academy of Sciences. 743: 121-39; discussion 1. PMID 7802410 DOI: 10.1111/j.1749-6632.1994.tb55790.x |
0.559 |
|
| 1993 |
Gallyas F, Hsu M, Buzsáki G. Four modified silver methods for thick sections of formaldehyde-fixed mammalian central nervous tissue: 'dark' neurons, perikarya of all neurons, microglial cells and capillaries. Journal of Neuroscience Methods. 50: 159-64. PMID 8107497 DOI: 10.1016/0165-0270(93)90004-B |
0.583 |
|
| 1992 |
Gallyas F, Zoltay G, Dames W. Formation of "dark" (argyrophilic) neurons of various origin proceeds with a common mechanism of biophysical nature (a novel hypothesis). Acta Neuropathologica. 83: 504-9. PMID 1621506 DOI: 10.1007/Bf00310027 |
0.372 |
|
| 1992 |
Gallyas F, Hsu M, Buzsaki G. Delayed degeneration of the optic tract and neurons in the superior colliculus after forebrain ischemia. Neuroscience Letters. 144: 177-9. PMID 1436699 DOI: 10.1016/0304-3940(92)90744-R |
0.572 |
|
| 1992 |
Gallyas F, Zoltay G, Horváth Z. Light microscopic response of neuronal somata, dendrites and axons to post-mortem concussive head injury. Acta Neuropathologica. 83: 499-503. PMID 1377858 DOI: 10.1007/Bf00310026 |
0.333 |
|
| 1992 |
Gallyas F, Zoltay G, Balás I. An immediate light microscopic response of neuronal somata, dendrites and axons to contusing concussive head injury in the rat. Acta Neuropathologica. 83: 394-401. PMID 1374205 DOI: 10.1007/Bf00713531 |
0.366 |
|
| 1992 |
Satoh J, Gallyas F, Endoh M, Yamamura T, Kunishita T, Kobayashi T, Tabira T. Establishment of mouse-immortalized hybrid clones expressing characteristics of differentiated neurons derived from the cerebellar and brain stem regions. Journal of Neurobiology. 23: 905-19. PMID 1359006 DOI: 10.1002/Neu.480230711 |
0.354 |
|
| 1992 |
Satoh J, Gallyas F, Endoh M, Yamamura T, Kunishita T, Tabira T. Coexistence of cholinergic, catecholaminergic, serotonergic, and glutamatergic neurotransmitter markers in mouse clonal hybrid neurons derived from the septal region. Journal of Neuroscience Research. 32: 127-37. PMID 1357185 DOI: 10.1002/Jnr.490320202 |
0.359 |
|
| 1991 |
Gallyas F, Satoh J, Takeuchi AM, Konishi Y, Kunishita T, Tabira T. Free amino acid- and “monoamine”-content of immortalized neuronal cell lines Neuroscience Research Supplements. 16: 24. DOI: 10.1016/0921-8696(91)90709-V |
0.306 |
|
| 1990 |
Gallyas F, Güldner FH, Zoltay G, Wolff JR. Golgi-like demonstration of "dark" neurons with an argyrophil III method for experimental neuropathology. Acta Neuropathologica. 79: 620-8. PMID 1694382 DOI: 10.1007/Bf00294239 |
0.377 |
|
| 1990 |
van den Pol AN, Gallyas F. Trauma-induced Golgi-like staining of neurons: a new approach to neuronal organization and response to injury. The Journal of Comparative Neurology. 296: 654-73. PMID 1694192 DOI: 10.1002/Cne.902960410 |
0.364 |
|
| 1982 |
Liposits Z, Görcs T, Gallyas F, Kosaras B, Sétáló G. Improvement of the electron microscopic detection of peroxidase activity by means of the silver intensification of the diaminobenzidine reaction in the rat nervous system. Neuroscience Letters. 31: 7-11. PMID 6750453 DOI: 10.1016/0304-3940(82)90045-3 |
0.325 |
|
| Show low-probability matches. |